The VA National Acquisition Center plans an unrestricted procurement for Pioglitazone HCL Tablets to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. One contract will be awarded for a base period of one year plus four pre-priced one-year option periods. The drug will be distributed through the VA’s Pharmaceutical Prime Vendor Programs, and offerors must state the exact label name and provide a unique NDC/UPC number with standard bottle packaging. Estimated annual usage quantities are specified for 15mg, 30mg, and 45mg tablets in 30, 90, and 500-count bottles. No budget amount or performance location is indicated in the notice.